Phosphate Binders in CKD: ‟New Kids on the Block”

Muhammad Umair  Afzal; Shafeeq  Cheema

doi:10.53778/pjkd31089

Phosphate Binders in CKD: ‟New Kids on the Block”

Autores/as

Muhammad Umair Afzal
Shafeeq Cheema Jinah Hospital, Lahore

DOI:

https://doi.org/10.53778/pjkd31089

Palabras clave:

hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxide

Resumen

Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.